Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Feb 17, 2024 5:02pm
106 Views
Post# 35886144

RE:RE:RE:AEZS approached CZO

RE:RE:RE:AEZS approached CZOAnd he is a consultant for the company via his own company Prodev Pharma and managed to give himself a nice termination package as well.

Employment Agreements
 
Gilles Gagnon provides his services as President and Chief Executive Officer to the Company pursuant to a service agreement (the “Service Agreement”) with Prodev Pharma Inc. (the “Consultant”) dated January 1, 2017. In the event of termination of the Service Agreement following a change in control of the Company or a material change in the terms and conditions of the Service Agreement, the Service Agreement provides that the Company shall pay the Consultant an amount equal to the aggregate of: (i) the monthly fees which would otherwise have been payable to the
Consultant for a period of two years from the date of such termination or expiration, being $960,000; and (ii) the amount equal to all bonuses paid or accrued for the benefit of the Consultant during the 24 months immediately prior to the date of such termination or expiration.

and if you look at the management team of AEZS, Fratta and Turpin reside in Quebec. Why does this look like a old boys club? 

based on AEZS share ownership, you can be sure they will take care of their valued shareholders as well and continue the record of shareholder value destruction

Aeterna Zentaris Support. Ceapro has similarly entered into lock-up agreements with all of the
directors and officers of Aeterna Zentaris (the “Ceapro Lock-Up Agreements”) whereby it has
secured their support for the approval of the Arrangement by Aeterna Zentaris shareholders who
beneficially own, or exercise control or direction over, 6,756 Aeterna Zentaris Shares (as defined
below), representing approximately 0.14% of the outstanding Aeterna Zentaris Shares as of January 2, 2024.

<< Previous
Bullboard Posts
Next >>